Skip to main content
Oversight Institute
Category: Resilience and Concentration

Provider Concentration

Also known as: Market Concentration (provider-side), Provider Market Concentration
Simply put

Provider concentration describes the degree to which the supply of a good or service within a market is controlled by a small number of providers. In sectors such as health care, for example, a highly concentrated hospital market means relatively few providers serve a given area. The term is generally used to describe the competitive structure of a market rather than any single buyer's reliance on a particular supplier.

Formal definition

Provider concentration is a market-level measure of how the supply side of a defined market is distributed across providers, indicating the extent to which a small number of entities account for a large share of available supply. In health care contexts, provider (often hospital) concentration has been associated in the literature with higher commercial medical prices, though the magnitude and conditions of these effects remain subject to disagreement; similarly, concentration on the insurer side has been linked to fewer plan choices and, per some analyses, higher premiums due to reduced competition. This concept is distinct from an individual organization's supplier or third-party dependency: provider concentration characterizes the competitive structure of a market as a whole, whereas measures such as supplier concentration analysis assess how dependent a specific organization is on a limited number of suppliers for operational continuity. The two should not be conflated, as they describe risk at different levels of analysis.

Why it matters

Provider concentration matters because the competitive structure of a market shapes the terms, prices, and choices available to every buyer operating within it, independent of any single organization's own sourcing decisions. In health care contexts, provider concentration, often measured at the hospital level, has been associated in the literature with higher commercial medical prices, though disagreement remains over the magnitude of these effects and the conditions under which they hold. Concentration on the insurer side has similarly been linked in some analyses to fewer plan choices and, due to reduced competition, higher premiums. These findings illustrate why understanding market-level concentration is relevant to organizations that purchase within concentrated sectors, even where those organizations retain multiple direct supplier relationships.

A critical reason this term warrants careful treatment is that it is frequently conflated with an individual organization's dependency on a limited number of suppliers. Provider concentration describes how supply is distributed across a market as a whole; it does not, on its own, measure whether a particular buyer is over-reliant on a specific vendor. A buyer may be exposed to a highly concentrated market yet still maintain diversified sourcing within that market, or conversely may be heavily dependent on a single supplier operating in an otherwise competitive market. Treating the two as interchangeable can lead to misdiagnosis of where risk actually resides.

For risk and procurement professionals, recognizing provider concentration helps explain structural pressures, such as pricing power or limited substitution options, that no amount of internal supplier diversification can fully offset when the market itself offers few alternatives. It provides context for interpreting supplier behavior and price movements, but it should be assessed alongside, not in place of, organization-level dependency measures.

Who it's relevant to

Procurement and Sourcing Teams
Teams sourcing goods or services in sectors with few competing providers benefit from understanding market concentration as context for pricing power and limited substitution options. This awareness informs negotiation expectations and sourcing strategy, but it should be distinguished from, and used alongside, an assessment of the organization's own dependency on specific suppliers.
Risk and Resilience Professionals
Provider concentration signals structural conditions in a market that may constrain a buyer's ability to switch or diversify. Because it is a market-level measure, it does not by itself indicate an organization's operational exposure to a single supplier; resilience professionals typically pair it with supplier concentration or dependency analysis conducted at the organizational level.
Health Care Purchasers and Payers
In health care contexts, concentration among hospitals or insurers is particularly salient. Literature has associated higher hospital concentration with higher commercial medical prices and higher insurer concentration with fewer plan choices and, in some analyses, higher premiums, though the magnitude and conditions of these effects remain subject to disagreement. Purchasers operating in these markets can use concentration as one input when interpreting price and choice conditions.
Policy and Market Analysts
Analysts studying competition and consolidation rely on provider concentration as a descriptive measure of market structure. It supports assessment of how supply is distributed across providers but does not, on its own, establish causation for any given price or quality outcome, which remains an area of ongoing study and debate.

Inside Provider Concentration

Concentration within a defined market or category
Provider concentration, in the sense flagged by prior definitions, refers to the degree to which a limited number of providers account for the available supply within a defined market, service category, or geography. It is a structural property of the supply landscape rather than a measure of any single organization's dependency on a particular provider.
Distinction from single-source dependency and single point of failure
Concentration describes the shape of the overall provider population, whereas single-source dependency describes an organization's reliance on one provider for a given need, and single point of failure describes a component whose loss disrupts a process. These are related but separate concepts and should not be treated as interchangeable.
Measurement and observed market effects
Concentration is commonly characterized by how few providers hold the largest share of supply in a market. Many studies examining concentrated markets, such as certain hospital or insurer markets, report associations with higher prices or reduced choice, though disagreement remains on the magnitude and the circumstances under which these effects hold.
Scope boundary
As used here, provider concentration is a market-level or category-level structural measure. It does not by itself quantify an individual organization's exposure to, or dependency on, a specific provider; that is a distinct assessment addressed by dependency, concentration-of-spend, and single-source analyses within third-party risk management.

Common questions

Answers to the questions practitioners most commonly ask about Provider Concentration.

Is provider concentration the same as an individual organization's dependency on a single vendor?
Not necessarily, and the two senses should be kept distinct. In one usage, provider concentration describes a market-level condition, how few providers supply a given service or good within a market or sector. In another, it refers to the degree to which a single organization's exposure is aggregated across a small number of providers. Because the same phrase can carry either meaning, programs typically clarify which sense is intended: the market-structure view addresses competition and availability across a sector, while the dependency view addresses one organization's own exposure. Conflating them can lead to mismatched controls, so state your unit of analysis before assessing concentration.
Does evidence firmly establish that concentrated provider markets always produce worse outcomes?
The evidence is directional rather than absolute. Many studies associate more concentrated markets with effects such as higher prices or reduced choice, but disagreement remains on the magnitude and the circumstances under which those effects hold. Treat concentration as a risk indicator that warrants scrutiny rather than as a determinant of a fixed outcome. Depending on the market, the specific service, and local conditions, the practical impact can vary, so conclusions should be qualified rather than stated as consensus.
How do teams decide which unit of analysis to use when measuring provider concentration?
The choice typically follows the question being asked. If the concern is whether a viable alternative exists should a provider fail or exit, an organization-level dependency view is usually appropriate, examining how exposure aggregates across providers for a given service. If the concern is market availability, pricing pressure, or systemic fragility across a sector, a market-level view fits better. Many programs document the unit of analysis explicitly in their methodology so that later readers do not misread a market metric as an organizational one, or vice versa.
How can concentration hidden below the first tier be identified?
Direct visibility usually extends only to first-tier relationships, so lower-tier or Nth-party concentration is harder to observe. In practice, programs may combine contractual disclosure requirements, supplier-provided mapping of their own critical dependencies, and questionnaire responses, though these are self-reported and often incomplete. This means concentration that emerges when multiple direct providers rely on a common underlying provider can go undetected. Any assessment of below-first-tier concentration should note this limited visibility as a scope constraint rather than presenting it as complete.
How often should concentration assessments be refreshed?
Concentration is not static; provider markets consolidate, contracts change, and dependencies shift, so a point-in-time assessment can become stale. Many programs tie refresh cadence to risk tier, reassessing higher-tier or more concentrated exposures more frequently and lower-tier ones on a longer cycle. Event-driven reviews, triggered by mergers, provider exits, or material contract changes, are also common. The appropriate interval depends on how quickly the relevant market and dependencies move, so a fixed universal cadence is generally avoided.
How should concentration findings be distinguished from single point of failure and single-source dependency?
These are related but distinct and should not be merged in reporting. Single-source dependency describes reliance on one provider for a given service; a single point of failure is a component whose failure disrupts the whole; concentration describes the aggregation of exposure across a small number of providers, which may or may not amount to either of the others. A concentrated exposure is not automatically a single point of failure if substitutes exist, and a single-source arrangement may be tolerable where alternatives can be activated. Assessments typically label each condition separately so mitigation is matched to the actual exposure.

Common misconceptions

Provider concentration is the same as an organization's dependency on a given supplier.
Provider concentration describes how few providers make up a market or category; it is a structural feature of the supply landscape. An organization's dependency on a specific provider is a separate measure that must be assessed independently, since a firm can be heavily dependent on one provider even in an unconcentrated market, and vice versa.
Concentrated provider markets reliably and uniformly produce worse outcomes such as higher prices or reduced choice.
While many studies of concentrated markets report associations with higher prices or reduced choice, there is not full agreement on the magnitude or the conditions under which these effects occur. The relationship should be described conditionally rather than as a settled, universal outcome.
Provider concentration is synonymous with single point of failure.
A single point of failure concerns a component whose loss disrupts a process, while concentration concerns the distribution of supply across providers in a market. A concentrated market may or may not translate into a single point of failure for any specific organization, depending on that organization's own arrangements.

Best practices

Clearly state whether an analysis is measuring market-level provider concentration or an individual organization's dependency on specific providers, and avoid conflating the two.
Treat concentration, single-source dependency, and single point of failure as distinct measures, and assess each explicitly rather than assuming one implies another.
When citing observed effects of concentrated markets, use qualified, conditional language that reflects the disagreement in the evidence on magnitude and circumstances.
Document the defined market, category, or geography over which concentration is measured, since concentration is only meaningful relative to a stated boundary.
Note the scope limitation that provider concentration does not by itself quantify a firm's exposure to a given provider, and supplement it with dependency-focused analysis where that exposure matters.
Promotional banner highlighting failures found in PCI audits and how to spot the gaps